Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Equity Ratio (2016 - 2026)

Pharma-Bio Serv (PBSV) has disclosed Equity Ratio for 15 consecutive years, with 0.87 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio rose 3.66% year-over-year to 0.87, compared with a TTM value of 0.87 through Oct 2025, up 3.66%, and an annual FY2025 reading of 0.87, up 3.66% over the prior year.
  • Equity Ratio was 0.87 for Q4 2025 at Pharma-Bio Serv, down from 0.88 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.88 in Q3 2025 and bottomed at 0.71 in Q1 2021.
  • Average Equity Ratio over 5 years is 0.8, with a median of 0.8 recorded in 2023.
  • The sharpest move saw Equity Ratio decreased 12.72% in 2021, then grew 11.99% in 2022.
  • Year by year, Equity Ratio stood at 0.79 in 2021, then rose by 1.4% to 0.8 in 2022, then grew by 1.06% to 0.81 in 2023, then rose by 3.89% to 0.84 in 2024, then increased by 3.66% to 0.87 in 2025.
  • Business Quant data shows Equity Ratio for PBSV at 0.87 in Q4 2025, 0.88 in Q3 2025, and 0.87 in Q2 2025.